[PHARMA] QoQ TTM Result on 31-Dec-2019 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Dec-2019 [#4]
Profit Trend
QoQ- -541.27%
YoY- -451.37%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Revenue 2,806,171 2,898,216 2,854,343 2,820,530 2,701,491 2,572,302 2,553,141 6.48%
PBT -189,175 -189,383 -191,228 -191,865 58,549 72,267 71,756 -
Tax 43,758 43,048 44,548 42,418 -24,693 -23,482 -26,467 -
NP -145,417 -146,335 -146,680 -149,447 33,856 48,785 45,289 -
-
NP to SH -144,778 -145,739 -146,437 -149,219 33,816 48,386 44,499 -
-
Tax Rate - - - - 42.17% 32.49% 36.88% -
Total Cost 2,951,588 3,044,551 3,001,023 2,969,977 2,667,635 2,523,517 2,507,852 11.43%
-
Net Worth 345,040 357,891 350,047 336,573 516,387 518,564 528,825 -24.71%
Dividend
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Div 26,125 22,204 22,188 22,144 27,347 40,348 44,226 -29.53%
Div Payout % 0.00% 0.00% 0.00% 0.00% 80.87% 83.39% 99.39% -
Equity
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Net Worth 345,040 357,891 350,047 336,573 516,387 518,564 528,825 -24.71%
NOSH 261,705 261,705 261,229 261,229 261,229 261,229 260,505 0.30%
Ratio Analysis
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
NP Margin -5.18% -5.05% -5.14% -5.30% 1.25% 1.90% 1.77% -
ROE -41.96% -40.72% -41.83% -44.33% 6.55% 9.33% 8.41% -
Per Share
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 1,073.54 1,109.43 1,092.66 1,081.04 1,035.84 987.13 980.07 6.24%
EPS -55.39 -55.79 -56.06 -57.19 12.97 18.57 17.08 -
DPS 10.00 8.50 8.50 8.50 10.50 15.50 17.00 -29.72%
NAPS 1.32 1.37 1.34 1.29 1.98 1.99 2.03 -24.88%
Adjusted Per Share Value based on latest NOSH - 261,229
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
RPS 194.70 201.09 198.05 195.70 187.44 178.48 177.15 6.48%
EPS -10.05 -10.11 -10.16 -10.35 2.35 3.36 3.09 -
DPS 1.81 1.54 1.54 1.54 1.90 2.80 3.07 -29.62%
NAPS 0.2394 0.2483 0.2429 0.2335 0.3583 0.3598 0.3669 -24.71%
Price Multiplier on Financial Quarter End Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 28/06/19 29/03/19 -
Price 4.32 2.22 1.26 2.06 2.44 2.84 2.27 -
P/RPS 0.40 0.20 0.12 0.19 0.24 0.29 0.23 44.47%
P/EPS -7.80 -3.98 -2.25 -3.60 18.82 15.29 13.29 -
EY -12.82 -25.13 -44.49 -27.76 5.31 6.54 7.53 -
DY 2.31 3.83 6.75 4.13 4.30 5.46 7.49 -54.25%
P/NAPS 3.27 1.62 0.94 1.60 1.23 1.43 1.12 103.87%
Price Multiplier on Announcement Date
30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 CAGR
Date 19/11/20 19/08/20 19/05/20 20/02/20 20/11/19 23/08/19 16/05/19 -
Price 5.72 4.42 1.88 2.04 2.21 2.66 2.36 -
P/RPS 0.53 0.40 0.17 0.19 0.21 0.27 0.24 69.33%
P/EPS -10.33 -7.92 -3.35 -3.57 17.04 14.33 13.82 -
EY -9.68 -12.62 -29.82 -28.04 5.87 6.98 7.24 -
DY 1.75 1.92 4.52 4.17 4.75 5.83 7.20 -60.95%
P/NAPS 4.33 3.23 1.40 1.58 1.12 1.34 1.16 140.05%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment